Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Larsen

Showing results (1061-1070 of 1,301) with videos related to

Pageof 131
Sort By:
Annals of Internal Medicine|August 1, 1985
Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agentsJ Pedersen-Bjergaard, J Ersbøll, H M Sørensen, et al.
Dalton Transactions (Cambridge, England : 2003)|September 22, 2011
A family of 13 tetranuclear zinc(II)-lanthanide(III) complexes of a [3+3] Schiff-base macrocycle derived from 1,4-diformyl-2,3-dihydroxybenzeneHumphrey L C Feltham, Frederik Klöwer, Scott A Cameron, et al.
Cancer|January 1, 1980
Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan)J Pedersen-Bjergaard, N I Nissen, H M Sørensen, et al.
Translational Oncology|June 25, 2025
Targeting drug resistant colorectal cancer with apigenin nanoarchitecturesPouya Goleij, Saeid Ferdousmakan, Mohammad Amin Khazeei Tabari, et al.
Physiological Reports|March 16, 2024
The carbon monoxide prodrug oCOm-21 increases Ca<sup>2+</sup> sensitivity of the cardiac myofilamentFergus M Payne, Samantha Nie, Gary M Diffee, et al.
Cytokine|May 3, 2025
The role of interleukin (IL)-2 cytokine family in Parkinson's diseasePouya Goleij, Alireza Amini, Mohammad Amin Khazeei Tabari, et al.
Cardiovascular Research|April 29, 2009
Cardiac peroxisome proliferator-activated receptor-alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional lossAnne D Hafstad, Ahmed M Khalid, Martin Hagve, et al.
Acta Medica Scandinavica|January 1, 1982
Immunosuppression and the additive effect of plasma exchange in treatment of rapidly progressive glomerulonephritisH Thysell, P Bygren, U Bengtsson, et al.
The Journal of Physical Chemistry. B|June 23, 2012
Chemical inhomogeneity in the ultrafast dynamics of the DXCF cyanobacteriochrome Tlr0924Lucy H Freer, Peter W Kim, Scott C Corley, et al.
Acta Medica Scandinavica|January 1, 1988
Cytostatic treatment of glomerular diseases. V. Treatment of glomerulonephritis with cyclophosphamide plus prednisone, azathioprine plus prednisone and cyclophosphamide as monotherapy. A comparative study. A report from a Copenhagen Study Group of Renal DiseasesM Brahm, J T Balsløv, M Brammer, et al.
Pageof 131

Showing results (1061-1070 of 1,301) with videos related to

Sort By:
Pageof 131
Annals of Internal Medicine|August 1, 1985
Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agentsJ Pedersen-Bjergaard, J Ersbøll, H M Sørensen, et al.
Dalton Transactions (Cambridge, England : 2003)|September 22, 2011
A family of 13 tetranuclear zinc(II)-lanthanide(III) complexes of a [3+3] Schiff-base macrocycle derived from 1,4-diformyl-2,3-dihydroxybenzeneHumphrey L C Feltham, Frederik Klöwer, Scott A Cameron, et al.
Cancer|January 1, 1980
Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan)J Pedersen-Bjergaard, N I Nissen, H M Sørensen, et al.
Translational Oncology|June 25, 2025
Targeting drug resistant colorectal cancer with apigenin nanoarchitecturesPouya Goleij, Saeid Ferdousmakan, Mohammad Amin Khazeei Tabari, et al.
Physiological Reports|March 16, 2024
The carbon monoxide prodrug oCOm-21 increases Ca<sup>2+</sup> sensitivity of the cardiac myofilamentFergus M Payne, Samantha Nie, Gary M Diffee, et al.
Cytokine|May 3, 2025
The role of interleukin (IL)-2 cytokine family in Parkinson's diseasePouya Goleij, Alireza Amini, Mohammad Amin Khazeei Tabari, et al.
Cardiovascular Research|April 29, 2009
Cardiac peroxisome proliferator-activated receptor-alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional lossAnne D Hafstad, Ahmed M Khalid, Martin Hagve, et al.
Acta Medica Scandinavica|January 1, 1982
Immunosuppression and the additive effect of plasma exchange in treatment of rapidly progressive glomerulonephritisH Thysell, P Bygren, U Bengtsson, et al.
The Journal of Physical Chemistry. B|June 23, 2012
Chemical inhomogeneity in the ultrafast dynamics of the DXCF cyanobacteriochrome Tlr0924Lucy H Freer, Peter W Kim, Scott C Corley, et al.
Acta Medica Scandinavica|January 1, 1988
Cytostatic treatment of glomerular diseases. V. Treatment of glomerulonephritis with cyclophosphamide plus prednisone, azathioprine plus prednisone and cyclophosphamide as monotherapy. A comparative study. A report from a Copenhagen Study Group of Renal DiseasesM Brahm, J T Balsløv, M Brammer, et al.
Pageof 131